[MARKET ANALYSIS] Stocks gain as diplomacy hopes rise; Hapag-Lloyd lifts outlook, whilst Lindt issues a profit warning

European bourses (STOXX 600 +0.4%) are broadly firmer this morning, with sentiment buoyed by increased hopes of US-Iran diplomacy – although uncertainty remains (see commodities for details). The energy complex has waned off best levels throughout the London morning, which has also helped lift the equities complex. European sectors hold a positive bias. Tech takes the top spot, reversing some of the pressure seen in the prior session. Industrials and Basic Resources complete the top three, with the latter rebounding from the pressure seen on Monday. To the downside, Food Beverage & Tobacco is joined by Energy and Optimised Personal Care. Key Movers: AstraZeneca (+2%, Co. is to invest USD 2bln in Summit Therapeutics), Airbus (-0.7%, Co. faces slower-than-expected deliveries in September, sources say), Hapag-Lloyd (+3.5%, Co. raises outlook for FY26, citing strong market demand and the ongoing positive development of spot freight rates), Lindt (-6%, issues profit warning), Julius Baer (+8%, FINMA concludes investigation). US equity futures are currently trading on either side of the unchanged mark; the NQ (+0.1%) posts mild gains, whilst the ES and RTY are lower by that same magnitude.  Focus today will be on President Trump’s meeting with AI heads, where discussions will be on AI oversight/safety and competition with China. The day ahead is packed with a number of Fed speakers, as well as US JOLTS job openings. It is also worth noting that Trump's pharma tariffs (announced in Apr), will take effect on a number of key nations today. A 15% levy has been put on the EU, South Korea and Switzerland. Some analysts opine that the new measures could see a reduction in medication available to customers, and could even lead to higher prices.